Product
Alendronate + Vitamin D3
Aliases
alendronate 70-mg/vitamin D3 5600 IU combination tablet (Fosamax Plus), MK-0217A
1 clinical trial
2 indications
Indication
OsteoporosisIndication
PostmenopausalClinical trial
A 6-Month, Randomized, Open-Label, Active-Comparator Controlled, Parallel-Group Study With a 6-Month Extension to Evaluate the Safety and Efficacy of Alendronate Sodium 70 mg/Vitamin D3 5600 I.U. Combination Tablets Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in ChinaStatus: Completed, Estimated PCD: 2013-01-10